STACY MCCLELLAND: Open Payments
NPI 1629766985 · SAN ANTONIO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 29 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $343 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $185 |
| GENZYME CORPORATION | 1 | $118 |
| Madrigal Pharmaceuticals | 1 | $105 |
| Mallinckrodt Hospital Products Inc. | 2 | $69 |
| Ardelyx, Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 2 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
Products named: DUPIXENT, CREON, REZDIFFRA, TERLIVAZ, LINZESS, IBSRELA, VOQUEZNA, TREMFYA.
Industry payments across FL — which companies pay providers there.
